Federal policy is again chasing the same unicorn: lower spending without higher taxes or leaner benefits. The ACCESS model is the latest CMMI attempt to test whether technology, care redesign, and specialty engagement can create real productivity gains in a sector where cost growth is stubborn and every "saving" is someone else's revenue cut. That is worth testing, but finance teams should keep their priors intact: healthcare rarely gets cheaper by press release, and AI is not a reserve strategy. The more immediate signals are mixed but concrete. Early 2026 ACA marketplace data point to effectuated membership that is smaller and somewhat sicker than prior expectations, though apparently not as bad as public-market angst implied. That matters for morbidity, retention, risk adjustment transfers, and 2027 rate filing posture.

On the provider side, CMS' proposed FY 2027 IPPS update of 2.4% will not feel generous to hospitals still arguing their cost structure lives in a different zip code. Pair that with a proposed nationwide mandatory expansion of CJR and the message is familiar: base rates stay tight while operational risk shifts into value-based models. Meanwhile, the perennial prices-versus-utilization debate continues, but for operators the practical answer is "both, depending on whether you mean spending levels or spending growth" -- semantics matter because policy remedies differ.

At the state level, Medicaid remains a laboratory for noble intentions and avoidable execution errors. Work requirements are back, with all the expected churn, exemption complexity, and redetermination noise. Specialized Medicaid coverage for foster youth highlights a harsher truth: targeted benefit design without adequate networks, behavioral health capacity, or high-cost therapy coverage is just a more bespoke version of underfunding.